Image Guided Radiation Therapy For Prostate Cancer
Conditions
Prostate Cancer
Conditions: official terms
Prostatic Neoplasms
Conditions: Keywords
Prostate adenocarcinoma treated by radiotherapy
Study Type
Interventional
Study Phase
Phase 3
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Intervention
Name: Control position by 3DOBI before the fraction
Type: Procedure
Overall Status
Recruiting
Summary
During the 7 to 8 weeks of conformal radiotherapy for prostate carcinoma, the prostate has an intra-pelvic motion which is not detectable by the conventional portal imaging. This prostate motion may lead to a mistargeting, which possibly decreases the local control. On the other hand, the new 3D on board imaging (3D OBI) allows to localize the target but is expensive. The cost/effectiveness ratio is not well established, as well as the frequency of using such imaging during the course of radiation.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: N/A
Gender: Male
Criteria: Inclusion Criteria:

- prostate adenocarcinoma

- intermediate / high risk group

- N0 or N -

- treatment by conformal radiotherapy (including or not IMRT), with or without androgen deprivation

Exclusion Criteria:

- pelvic irradiation

- metal objects in the pelvis
Location
Institut Gustave Roussy
Villejuif, France
Status: Recruiting
Contact: Renaud DE CREVOISIER, MD - 00 33 142 11 45 66 - renaud.de.crevoisier@igr.fr
Start Date
June 2007
Completion Date
September 2007
Sponsors
Gustave Roussy, Cancer Campus, Grand Paris
Source
Gustave Roussy, Cancer Campus, Grand Paris
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page